RPS15AP18

Across TCGA pan-cancer cohorts, RPS15AP18 RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of RPS15AP18’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RPS15AP18 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS15AP18 is over-expressed in tumor, although a few such as ESCA show the opposite, repressed pattern.

COAD, LUAD, and KIRC are the cancer types where RPS15AP18 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS15AP18 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	II,III,IV	+0.071	.021	3	view →
LUAD	All	All	+0.087	.017	2	view →
KIRC	All	All	+0.030	.014	2	view →
ESCA	All	All	−0.390	.042	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 4 strongest of 4 lineages.

RPS15AP18–COAD

Open the COAD breakdown →